Visible‐Light Photoswitchable Benzimidazole Azo‐Arenes as β‐Arrestin2‐Biased Selective Cannabinoid 2 Receptor Agonists
Angewandte Chemie International Edition · 04.12.2023 · 62 (49)
DOI: 10.1002/anie.202306176 ↗Kurz gefasst
Fachartikel in der Zeitschrift Angewandte Chemie International Edition, online erschienen am 13.07.2023. Verfasst von Sophie A M Steinmüller und 7 weiteren Autor:innen. Beteiligte Einrichtung: Pharmazeutische und Medizinische Chemie, Institut für Pharmazie und Lebensmittelchemie, Julius-Maximilians-Universität Würzburg, Am Hubland, 97074, W…. Hauptthemen laut MEDLINE: Cannabinoid Receptor Agonists, Cannabinoids. Die Arbeit wurde bisher 32-mal zitiert (Crossref) und nennt 95 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Deutsche Forschungsgemeinschaft, NHS Health Scotland, Research Foundation-Flanders (FWO).
Abstract (Originalsprache)
The cannabinoid 2 receptor (CB 2 R) has high therapeutic potential for multiple pathogenic processes, such as neuroinflammation. Pathway‐selective ligands are needed to overcome the lack of clinical success and to elucidate correlations between pathways and their respective therapeutic effects. Herein, we report the design and synthesis of a photoswitchable scaffold based on the privileged structure of benzimidazole and its application as a functionally selective CB 2 R “efficacy‐switch”. Benzimidazole azo‐arenes offer huge potential for the broad extension of photopharmacology to a wide range of optically addressable biological targets. We used this scaffold to develop compound 10 d , a “ trans ‐on” agonist, which serves as a molecular probe to study the β‐arrestin2 (βarr2) pathway at CB 2 R. βΑrr2 bias was observed in CB 2 R internalization and βarr2 recruitment, while no activation occurred when looking at Gα 16 or mini‐Gα i . Overall, compound 10 d is the first light‐dependent functionally selective agonist to investigate the complex mechanisms of CB 2 R‐βarr2 dependent endocytosis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Pharmazeutische und Medizinische Chemie, Institut für Pharmazie und Lebensmittelchemie, Julius-Maximilians-Universität Würzburg, Am Hubland, 97074, Würzburg, Germany.
- Institut für Pharmakologie und Toxikologie, Julius-Maximilians-Universität Würzburg, Versbacher Str. 9, 97078, Würzburg, Germany.
- Laboratory of Toxicology, Department of Bioanalysis, Faculty of Pharmaceutical Sciences, Ghent University, Ottergemsesteenweg 460, 9000, Ghent, Belgium.
- Leibniz-Institut für Analytische Wissenschaften - ISAS-e.V., Bunsen-Kirchhoff-Straße 11, 44139, Dortmund, Germany.
- School of Medicine, Medical Sciences and Nutrition, Institute of Medical Sciences, University of Aberdeen Foresterhill, Aberdeen, AB25 2ZD, UK.
ORCID-Profile: Sophie A M Steinmüller, Michael Decker
Förderung
- Deutsche Forschungsgemeinschaft
- NHS Health Scotland
- Research Foundation-Flanders (FWO)
- Elitenetzwerk Bayern
Zitieren
APA
Steinmüller, S. A. M., Fender, J., Deventer, M. H., Tutov, A., Lorenz, K., Stove, C. P., Hislop, J. N., & Decker, M. (2023). Visible‐Light Photoswitchable Benzimidazole Azo‐Arenes as β‐Arrestin2‐Biased Selective Cannabinoid 2 Receptor Agonists. Angewandte Chemie International Edition, 62(49). https://doi.org/10.1002/anie.202306176
Vancouver
Steinmüller SAM, Fender J, Deventer MH, Tutov A, Lorenz K, Stove CP, et al. Visible‐Light Photoswitchable Benzimidazole Azo‐Arenes as β‐Arrestin2‐Biased Selective Cannabinoid 2 Receptor Agonists. Angewandte Chemie International Edition. 2023;62(49). doi:10.1002/anie.202306176
BibTeX
@article{Steinmller2023,
author = {Steinmüller, Sophie A M and Fender, Julia and Deventer, Marie H and Tutov, Anna and Lorenz, Kristina and Stove, Christophe P and Hislop, James N and Decker, Michael},
title = {Visible‐Light Photoswitchable Benzimidazole Azo‐Arenes as β‐Arrestin2‐Biased Selective Cannabinoid 2 Receptor Agonists},
journal = {Angewandte Chemie International Edition},
year = {2023},
volume = {62},
number = {49},
doi = {10.1002/anie.202306176}
}
EUVIMED